C4 Therapeutics Inc
NASDAQ:CCCC
Cash Flow Statement
Cash Flow Statement
C4 Therapeutics Inc
Sep-2020 | Dec-2020 | Mar-2021 | Jun-2021 | Sep-2021 | Dec-2021 | Mar-2022 | Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | Jun-2023 | Sep-2023 | Dec-2023 | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow | |||||||||||||||
Net Income |
(65)
|
(66)
|
(87)
|
(87)
|
(90)
|
(84)
|
(95)
|
(99)
|
(107)
|
(128)
|
(131)
|
(140)
|
(135)
|
(132)
|
|
Depreciation & Amortization |
2
|
2
|
2
|
2
|
2
|
1
|
1
|
1
|
1
|
2
|
2
|
2
|
2
|
2
|
|
Stock-Based Compensation |
2
|
3
|
7
|
12
|
18
|
22
|
27
|
30
|
29
|
30
|
27
|
26
|
28
|
0
|
|
Other Non-Cash Items |
7
|
11
|
15
|
20
|
23
|
26
|
32
|
36
|
37
|
37
|
34
|
30
|
32
|
31
|
|
Cash Taxes Paid |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
|
Cash Interest Paid |
0
|
1
|
0
|
1
|
1
|
1
|
1
|
1
|
1
|
2
|
2
|
2
|
1
|
1
|
|
Change in Working Capital |
(9)
|
(13)
|
(22)
|
(14)
|
(18)
|
(30)
|
(27)
|
(31)
|
(34)
|
(17)
|
(17)
|
(2)
|
(11)
|
(7)
|
|
Cash from Operating Activities |
(64)
N/A
|
(67)
-5%
|
(92)
-37%
|
(79)
+14%
|
(83)
-5%
|
(87)
-5%
|
(89)
-2%
|
(93)
-5%
|
(102)
-10%
|
(106)
-3%
|
(112)
-6%
|
(109)
+3%
|
(112)
-2%
|
(107)
+5%
|
|
Investing Cash Flow | |||||||||||||||
Capital Expenditures |
(0)
|
(1)
|
(1)
|
(2)
|
(1)
|
(1)
|
(1)
|
(1)
|
(4)
|
(6)
|
(6)
|
(6)
|
(3)
|
(2)
|
|
Other Items |
(121)
|
(190)
|
(251)
|
(114)
|
(183)
|
(188)
|
(131)
|
(130)
|
(6)
|
64
|
122
|
104
|
139
|
160
|
|
Cash from Investing Activities |
(122)
N/A
|
(191)
-56%
|
(252)
-32%
|
(116)
+54%
|
(184)
-59%
|
(189)
-3%
|
(132)
+30%
|
(131)
+1%
|
(10)
+92%
|
58
N/A
|
116
+98%
|
98
-16%
|
136
+39%
|
158
+17%
|
|
Financing Cash Flow | |||||||||||||||
Net Issuance of Common Stock |
143
|
337
|
337
|
197
|
195
|
2
|
2
|
2
|
1
|
1
|
0
|
0
|
(0)
|
58
|
|
Net Issuance of Debt |
12
|
12
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(1)
|
(2)
|
(13)
|
(13)
|
|
Other |
0
|
0
|
0
|
170
|
170
|
169
|
170
|
(0)
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Cash from Financing Activities |
155
N/A
|
349
+125%
|
349
0%
|
367
+5%
|
365
-1%
|
171
-53%
|
172
+0%
|
2
-99%
|
2
-12%
|
1
-27%
|
(0)
N/A
|
(1)
-10 100%
|
(12)
-1 090%
|
45
N/A
|
|
Change in Cash | |||||||||||||||
Net Change in Cash |
(31)
N/A
|
91
N/A
|
4
-95%
|
172
+3 849%
|
98
-43%
|
(105)
N/A
|
(48)
+54%
|
(222)
-360%
|
(111)
+50%
|
(46)
+58%
|
3
N/A
|
(12)
N/A
|
12
N/A
|
97
+737%
|
|
Free Cash Flow | |||||||||||||||
Free Cash Flow |
(64)
N/A
|
(68)
-6%
|
(93)
-37%
|
(81)
+13%
|
(84)
-5%
|
(88)
-5%
|
(90)
-2%
|
(94)
-4%
|
(107)
-14%
|
(111)
-5%
|
(118)
-6%
|
(115)
+3%
|
(115)
+0%
|
(109)
+6%
|